Review
Open access
Sep 2026
Organoid-on-Chip Technologies in Precision Oncology: Bridging Patient-Specific Tumor Biology and Physiologically Relevant Drug Screening
This review synthesizes the biological rationale, technical principles, and translational applications of PDO–OoC integration, with an emphasis on recent clinical validation studies, AI integration, and post-FDA Modernization Act 2.0 regulatory evolution.
M. V. Bulbul, T. Demircan
· Organoids · 0 citations